Home › Bronchiolitis Obliterans Syndrome › North Carolina
Bronchiolitis Obliterans Syndrome clinical trials in North Carolina
7 studies for Bronchiolitis Obliterans Syndrome are looking for participants at sites in North Carolina.
Cities in North Carolina
An Efficacy and Safety Study of DFL24498 in the Treatment of AKC
- Duke Eye Center - Ophthalmology, Durham
RecruitingPhase 3
Ages 10 to 65 · All sexes · Updated Sep 21, 2026 · NCT07395232A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)
- Levine Cancer Institute, Charlotte
- Duke Cancer Center, Durham
RecruitingPhase 2
Ages 2 to 17 · All sexes · Updated Sep 15, 2026 · NCT07124078A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
- Wake Forest Baptist Medical Center, Winston-Salem
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 15, 2026 · NCT06585774Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
- University of North Carolina at Chapel Hill, Chapel Hill
- Levine Cancer Institute, Charlotte
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT05919511A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
- University of North Carolina At Chapel Hill, Chapel Hill
- Levine Cancer Institute, Charlotte
- Duke University Medical Center, Durham
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 20, 2026 · NCT06615050Ruxolitinib Plus Fostamatinib for Steroid Refractory cGvHD
- Duke, Durham
RecruitingPhase 1
Ages 18 to 80 · All sexes · Updated Jan 22, 2026 · NCT06233110A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- Levine Cancer Institute, Charlotte
- Duke University Hospital, Durham
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Dec 15, 2025 · NCT06619561From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.